Efficacy of Camrelizumab in Advanced Non-Small-Cell Lung Cancer and Prognostic Analysis of Different PET/CT Features

Table 4

Immunologic function.

		CD3+	CD4+	CD8+	CD4+/CD8+
Control group ()	Before
	After	a	a	a	a
Study group ()	Before
	After	ab	ab	ab	ab

Note: a indicated compared with before treatment and b indicated compared with the control group.